Magnum Hunter Resources Declares Monthly Cash Dividend on

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Magnum Hunter Resources Declares Monthly Cash Dividend on Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock

HOUSTON, TX--(Marketwired - May 1, 2015) - Magnum Hunter Resources Corporation ( NYSE : MHR ) ( NYSE MKT : MHR.PRC ) ( NYSE MKT : MHR.PRD ) ( NYSE MKT : MHR.PRE ) (the "Company" or "Magnum Hunter") announced today that it has declared a monthly cash dividend on the Company's 10.25% Series C Cumulative Perpetual Preferred Stock ("Series C Preferred Stock"), a monthly cash dividend on the Company's 8.0% Series D Cumulative Preferred Stock ("Series D Preferred Stock") and a monthly cash dividend on the Company's 8.0% Series E Cumulative Convertible Preferred Stock ("Series E Preferred Stock"). The outstanding shares of Series E Preferred Stock are represented by depositary shares (the "Depositary Shares"), each representing a 1/1,000 th interest of a share of Series E Preferred Stock.

The dividend on the Series C Preferred Stock, which is for the month of May 2015, is payable on June 1, 2015, to holders of record at the close of business on May 15, 2015. The payment will be an annualized 10.25% per share, which is equivalent to approximately $0.2135 per share, based on the $25.00 per share liquidation preference of the Series C Preferred Stock. The Series C Preferred Stock is currently listed on the NYSE MKT and trades under the ticker symbol "MHR.PRC".

The dividend on the Series D Preferred Stock, which is for the month of May 2015, is payable on June 1, 2015, to holders of record at the close of business on May 15, 2015. The payment will be an annualized 8.0% per share, which is equivalent to approximately $0.3333 per share, based on the $50.00 per share liquidation preference of the Series D Preferred Stock. The Series D Preferred Stock is currently listed on the NYSE MKT and trades under the ticker symbol "MHR.PRD".

The dividend on the Series E Preferred Stock, which is for the month of May 2015, is payable on June 1, 2015, to holders of record at the close of business on May 15, 2015. The payment will be an annualized 8.0% per share of Series E Preferred Stock, which is equivalent to approximately $166.6667 per share, based on the $25,000.00 per share liquidation preference of the Series E Preferred Stock (equivalent to approximately $0.1667 per Depositary Share, based on the $25.00 per Depositary Share liquidation preference). The Depositary Shares are currently listed on the NYSE MKT and trade under the ticker symbol "MHR.PRE". The payment of dividends to holders of the Depositary Shares will be made in accordance with the terms of the Deposit Agreement which governs the Depositary Shares.

As previously disclosed in a Form 8-K filed by the Company with the Securities and Exchange Commission on April 20, 2015, the payment by the Company of these preferred stock dividends for May 2015 is subject to the satisfaction of certain conditions set forth in an amendment to the Company's senior secured revolving credit facility. See "Forward-Looking Statements" below.

About Magnum Hunter Resources Corporation

Magnum Hunter Resources Corporation and subsidiaries are a Houston, Texas-based independent exploration and production company engaged in the acquisition, development and production of crude oil, natural gas and natural gas liquids, primarily in the States of West Virginia, Ohio and North Dakota. The Company is presently active in three of the most prolific unconventional shale resource plays in the United States, namely the Marcellus Shale, Utica Shale, and Williston Basin/Bakken Shale. 

Availability of Information on the Company's Website

Magnum Hunter is providing a reminder that it makes available on its website (at www.magnumhunterresources.com ) a variety of information for investors, analysts and the media, including the following:

  • annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports as soon as reasonably practicable after the material is electronically filed with or furnished to the Securities and Exchange Commission;
  • the most recent version of the Company's Investor Presentation slide deck;
  • announcements of conference calls, webcasts, investor conferences, speeches and other events at which Company executives may discuss the Company and its business and archives or transcripts of such events;
  • press releases regarding annual and quarterly earnings, operational developments, legal developments and other matters; and
  • corporate governance information, including the Company's corporate governance guidelines, committee charters, code of conduct and other governance-related matters.

Magnum Hunter's goal is to maintain its website as the authoritative portal through which visitors can easily access current information about the Company. Over time, the Company intends for its website to become a primary channel for public dissemination of important information about the Company. Investors, analysts, media and other interested persons are encouraged to visit the Company's website frequently.

Certain information included on the Company's website constitutes forward-looking statements and is subject to the qualifications under the heading "Forward-Looking Statements" below and in the Company's Investor Presentation slide deck.

Forward-Looking Statements This press release includes "forward-looking statements." All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Actual results could vary significantly from those expressed or implied in such statements and are subject to a number of risks and uncertainties. Although Magnum Hunter believes that the expectations reflected in the forward-looking statements are reasonable, Magnum Hunter can give no assurance that such expectations will prove to be correct. The forward-looking statements involve risks and uncertainties that affect operations, financial performance, and other factors as discussed in filings made by Magnum Hunter with the Securities and Exchange Commission (SEC). Among the factors that could cause results to differ materially are those risks discussed in the periodic reports filed by Magnum Hunter with the SEC, including Magnum Hunter's Annual Report on Form 10-K for the fiscal year ended December 31, 2014 and its Quarterly Reports on Form 10-Q for the fiscal quarters ended after such fiscal year. You are urged to carefully review and consider the cautionary statements and other disclosures made in those filings, specifically those under the heading "Risk Factors." Forward-looking statements speak only as of the date of the document in which they are contained, and Magnum Hunter does not undertake any duty to update any forward-looking statements except as may be required by law. Furthermore, as previously disclosed in a Form 8-K filed by the Company with the SEC on April 20, 2015, the payment by the Company of the preferred stock dividends for May 2015 referred to in this press release is subject to the satisfaction of certain conditions set forth in an amendment to the Company's senior secured revolving credit facility. You are urged to review the Form 8-K for a description of such conditions. No assurance can be given regarding whether the Company will be able to satisfy these conditions.

Contact : Cham King AVP, Investor Relations ir@magnumhunterresources.com (832) 203-4560

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 158

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 132

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 152

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 129

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 94

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
vVARDIS Debuts on NYSE: Transforming Dental Care

Updated Category News Views 92

A New Chapter for Dental Tech Mark your calendars, folks. vVARDIS is stepping onto the New York Stock Exchange (NYSE) stage, waving the banner of NYSE:VVVV. Now, if you've ever sat in that squeaky dental chair feeling the dread of a drill, vVARDIS might just be the new hero in town. Founded by the dynamic duo, Dr. Haley and Dr. Goly Abivardi, they're on a mission to...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 147

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading

Top 5 Most Recently Viewed Articles

Chris Larsen's Strategic XRP Moves: Implications for Investors

Updated Category News Views 333

Overview of Chris Larsen's Recent XRP Transactions Chris Larsen, the influential co-founder and executive chairman of Ripple, has been actively transferring substantial amounts of XRP. Recently, he moved approximately $26 million worth of XRP to Coinbase, one of the most prominent cryptocurrency exchanges. This transfer is part of a larger pattern, contributing to an...

Continue Reading
Mastercard's Options Activity Insights: Market Trends Explored

Updated Category News Views 143

Understanding Mastercard's Recent Options Activity Mastercard is currently in the spotlight as investors engage in noteworthy bearish actions. This indicates a prevailing sentiment among wealthy clients regarding their perspective on the financial giant. Investor Insights on Mastercard Our analysis indicates that certain trades of interest have emerged in the options...

Continue Reading
Discover How CryptoGO Revolutionizes Memecoin Trading

Updated Category News Views 222

Transforming Memecoin Trading for Beginners CryptoGO is a innovative Telegram mini-app crafted specifically to ease the entry of newcomers into the world of memecoin trading. By harnessing the power of the Solana blockchain, CryptoGO revolutionizes how users engage with meme tokens, making the process both accessible and enjoyable. With support for fiat currency, users...

Continue Reading
Pyxis Oncology Updates on Financial Status and Future Plans

Updated Category News Views 325

Latest Developments at Pyxis Oncology Pyxis Oncology, Inc. has recently made headlines with its remarkable progress in the field of oncology. The development and ongoing trials of their innovative therapy, micvotabart pelidotin (MICVO), have shown encouraging preclinical results, highlighting its unique three-pronged mechanism of action. This mechanism enhances anti-tumor...

Continue Reading
Florida’s Cannabis Legalization Gains Momentum with Herald Support

Updated Category News Views 93

Support for Cannabis Legalization Gains Traction The Miami Herald, a notable publication in Florida with a rich history dating back to 1903, has come out strongly in favor of the state's cannabis legalization initiative known as Amendment 3. The proposal will be presented to voters in the upcoming election, marking a significant shift in public policy towards cannabis....

Continue Reading